Sun's generic of anticoagulant Plavix receives FDA approval

07/31/2011 | Business Standard (India)

The FDA is allowing Sun Pharmaceutical Industries to launch a 75-milligram dose of clopidogrel USP, a generic version of Sanofi and Bristol-Myers Squibb's anticoagulant Plavix. The tablet is given to patients with "acute coronary syndrome, recent myocardial infarction ... recent stroke or established peripheral arterial disease," Sun said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC